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ABSTRACT OF THESIS
A PILOT RANDOMIZED CONTROLLED TRIAL OF SMOKING CESSATION
INDUCTION TREATMENT FOR RURAL, UNDERSERVED CANCER SURVIVORS
ACROSS THE CONTINUUM OF MOTIVATION TO QUIT
The United States’ smoking prevalence has decreased substantially, but this
public health improvement is unevenly distributed across the population. A promising
individual-level approach to cancer control equity is to develop more acceptable and
efficacious interventions that are widely disseminated to rural and other disadvantaged
cancer survivors. Smoking cessation induction focuses not on long-term abstinence, but
on engaging people in the process of making quit attempts and may be ideal for hard-toreach populations. The aim of this pilot randomized controlled trial was to evaluate the
feasibility and acceptability of a smoking cessation induction intervention designed for
rural cancer survivors. The treatment group received a free, 2-week supply of nicotine
replacement therapy and brief advice pertinent to smoking cessation and resources for
unmet needs; the control group received no medication. Participants (n=49; 51.0% male)
were proactively recruited and procedures were accomplished via mail or phone. Data
collection occurred pre-intervention (Day 0) with Days 30 and 60 follow-up. The accrual
rate for the primary recruitment source (specifically, cancer registry) was 66.7%.
Retention was 75.0% and 72.0% for the treatment and control groups. Across follow-up,
the treatment group reported intention and confidence to quit (ps=.24-.55) and instances
of 50% smoking reduction (p=.15) that were similar to the control group, though they
reported more 24-hour quit attempts (p=.02). Treatment acceptability ratings were
favorable; no serious adverse events reported. Future studies should consider alternative
community-based recruitment strategies and interventions with greater intensity and more
interaction to bolster and sustain early gains in motivation and behavior change.
KEYWORDS: Smoking Induction, Tobacco Use, Cancer Survivors, Underserved, Rural,
Appalachia
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CHAPTER 1. INTRODUCTION
Over the last half century, smoking rates have steadily declined for adults in the
United States (US). The current estimated smoking rate is 15.1% as compared to 20.9%
only ten years ago (Jamal et al., 2015). Unfortunately, this public health improvement is
not uniformly distributed across all populations. Smoking is now concentrated among
individuals characterized by socioeconomic disadvantage (Hu et al., 2016; Nguyen et al.,
2016; Jamal et al., 2015), poor healthcare access (Hu et al., 2016; Jamal et al., 2015;
Nguyen et al., 2016), geographic sparsity and isolation (Doescher et al., 2006; Mitchell et
al., 2016; Lui et al., 2016), and inclusion in certain minority groups (Agaku et al., 2014).
For example, in a nationwide study of approximately 60,000 US adults, the LGBTQ+
community was found to smoke at a rate of 27.7% while its heterosexual-identified
counterpart smoked at a rate of 17.3% (Agaku et al., 2014). As another example, in a
study of over 1,000 US adults, rural Appalachians smoked at a rate of 33.0% which is
more than twice the national average (Cardarelli et al., 2021). As a final example,
nationwide data from more than 125,000 US adults showed that smokers at or below the
federal poverty line were less likely to make a quit attempt and less likely to use
evidence-based treatment when quitting compared to those with higher incomes (Babb et
al., 2017). In sum, there are clear population-level inequities in not only the rate of
smoking, but in smokers’ interest in quitting, quit attempts, and quit success (Babb et al.,
2017; CDC, 2011), all of which has serious, negative downstream effects on health
outcomes, including chronic disease incidence and mortality (Mozaffarian et al., 2015;
Singh et al., 2011; USDHHS, 2014).
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A cornerstone of the Healthy People 2020 tobacco use objectives was to increase
the percent of US adult smokers who made quit attempts in the past year from 50.0% to
80.0%, with a subordinate goal of increasing quit attempts that involve evidence-based
treatment (USDHHS, 2020). This goal was not met, with quit attempt rates from the last
five years hovering around 55.0% (Babb et al., 2017; USDHHS, 2020) and many
smokers still preferring to make quit attempts without treatment assistance (Babb et al.,
2017; Burris et al., 2021; Smith et al., 2015). Combined with data that indicates the
pervasiveness of smoking-related inequities, it is imperative new public health initiatives
and smoking cessation treatments address the social conditions in which smokers live, as
this likely impacts their willingness and ability to quit.
The focus herein is on smokers in rural, underserved areas in the US. For smokers
who live in rural communities, barriers to smoking cessation exist at the interpersonal,
community, and societal level. First, tobacco use has longstanding “rural roots” (Horn,
2012) that contribute to positive attitudes toward smoking and the perception of smoking
as a social norm. Second, some rural communities cite the value of “self-reliance” as
justification for why they should quit without seeking help (Cheesmond et al., 2019).
Third, rural regions are commonly designated as health professional shortage areas
(Salinsky, 2010; Streeter et al., 2020), which makes it difficult for interested smokers to
obtain smoking cessation treatment, thereby undercutting the likelihood of quit success.
Fourth, the low socioeconomic status of many people in rural areas further compounds
problems with treatment access, raises issues of treatment affordability (Hiscock et al.,
2012; Hutcheson et al., 2008; Salinsky, 2010), and contributes to a level of chronic stress
that can dull motivation to quit and decrease the likelihood of quit success (Businelle et
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al., 2010; Reid et al., 2010). Finally, as educational attainment is positively associated
with motivation to quit (CDC, 2011; Guillaumier et al., 2021) and successful smoking
cessation (CDC, 2011; Douthit et al., 2015; Lesueur et al., 2018; Piper et al., 2010), it is
noteworthy that higher educational attainment is not abundant in rural areas.
Given the deep-seated barriers to smoking cessation in rural areas, it would be
advantageous to go beyond the conventional approach of only providing evidence-based
treatment to the few who express readiness to quit and seek quit assistance and instead
offering it to all smokers (Burris et al., 2022; Cheung et al., 2020; Ranney et al., 2006;
Richter & Ellerbeck, 2015; Stoops et al., 2010). For this more proactive, populationbased approach, the appropriate treatment goal might be to prompt quit attempts not
necessarily achieve long-term abstinence (Burris et al., 2022). This treatment strategy–
that is, smoking cessation induction–has demonstrated success (Burris et al., 2015;
Carpenter et al., 2010; Carpenter et al., 2011; Chan et al., 2011; Dahne et al., 2020;
Hughes & Carpenter, 2006). For instance, when 849 adult smokers who were
unmotivated to quit were randomized to either nicotine replacement therapy (NRT)
sampling or practice quit attempt conditions, results showed that smokers who received
NRT were more likely to make a quit attempt and report abstinence at 6-month follow-up
than those in the control condition (Carpenter et al., 2011). In another randomized
controlled trial of 255 smokers who were unmotivated to quit, participants either received
motivational interviewing, health education, or brief advice over four weeks (Catley et
al., 2021). At 6-month follow-up, smokers who received motivational interviewing were
more likely to report confidence to quit and increases in NRT use compared to the brief
advice condition, though there was no difference when compared to health education
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(Catley et al., 2021). Given these and other positive results for smoking cessation
induction, it is possible this innovative and more equitable approach has potential to
move smokers in rural areas along the continuum of motivation to quit and increase the
likelihood of evidence-based treatment use among those who make quit attempts. If
smoking cessation induction is implemented in rural areas, and especially so if it is
community-based and remotely delivered, then it could narrow the rural-nonrural gap in
quit attempts made.
In cancer survivors, persistent smoking warrants significant attention because
smoking post-cancer diagnosis is linked to early cancer-specific and overall mortality,
second primary cancer, and cancer recurrence (USDHHS, 2014) and smoking cessation
improves cancer prognosis and quality of life (Bloom et al., 2017; Despoina et al., 2017;
USDHHS, 2020; Yang et al., 2020). Despite this, 15–30% of US cancer survivors are
current smokers (Burris et al., 2015; Mayer & Carlson, 2011; Swoboda, Walker, &
Huerta, 2019; Tseng et al., 2012; Westmaas et al., 2015), with higher rates in certain
groups, including cancer survivors who were smokers at cancer diagnosis (Burris et al.,
2015) and cancer survivors with low socioeconomic status (Burris et al., 2021; Hoover et
al., 2019). The current study seeks to address a gap in the literature whereby smoking
cessation treatments for cancer survivors focus almost exclusively on individuals who
present for cancer care and are ready to quit, and in no cases, target individuals who
reside in rural areas (Croyle, Morgan, & Fiore, 2019). In this pilot study with rural cancer
survivors across the continuum of motivation to quit, there are two objectives. The first
aim is to evaluate the feasibility and acceptability of a new approach to smoking
cessation induction (namely, NRT sampling + social support resource referral). The
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second aim is to describe the treatment’s impact on key motivational and behavioral
events in the process of smoking cessation relative to a control condition.
CHAPTER 2. METHOD
2.1 DESIGN
This is a pilot (Phase II) randomized controlled trial. Participants were
randomized 1:1 to either the control or treatment group. This study was approved by the
University of Kentucky Institutional Review Board and the Markey Cancer Center
Protocol Review and Monitoring Committee in Lexington, Kentucky. The study was preregistered at clinicaltrials.gov (NCT03316170), and a local data and safety monitoring
board met annually to monitor participant safety and serious adverse events.
2.2 SAMPLE
Participants consisted of adults ages 18-75, with a first primary head/neck and
cervical cancer diagnosis in the past five years. Participants were current smokers at
study enrollment. For this study, current smokers were individuals who have smoked ≥
100 cigarettes in their lifetime and an average of ≥ 10 cigarettes per day in the past 30
days. Participants were drawn from rural and/or Appalachian counties in Kentucky (see
Figure 1), with Appalachian counties included because like other predominately rural
areas that region has a high rate of smoking, cancer, and socioeconomic disadvantage
(ARC, 2009; Cardarelli et al., 2021). Consistent with past literature (Burris &
Andrykowski, 2010; Hauenstein et al., 2007; Stewart, Jameson, & Curtin, 2015), counties
were considered rural if they were classified as a 7, 8, or 9 on the USDA rural-urban
continuum codes, reflective of areas with low population density (< 19,999) and far
distance from metropolitan aeras (USDA, 2013). Appalachian status was determined by
the US Appalachian Regional Commission designation system, with 420 counties across
5

13 states considered Appalachian (ARC, 2009). Individuals were excluded from this
study if they reported any of the following: receipt of smoking cessation treatment in the
past 30 days; any FDA contraindication for NRT (e.g., heart disease); unreliable phone
access; pregnancy or plans to become pregnant within three months; unwillingness to use
birth control if of childbearing age; and no English literacy. Finally, individuals were
excluded if they reported diagnosis of a serious cognitive or psychiatric problem that
would interfere with informed consent or study procedures (e.g., schizophrenia,
dementia).
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FIGURE 1 KENTUCKY COUNTIES BY RURAL AND APPALACHIAN STATUS

Note. Geographical classification of Kentucky, by county, that outlines rural/Appalachia
designation.
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2.3 RECRUITMENT
Participants were recruited from multiple sources and there was a strong desire to
extend smoking cessation treatment to cancer survivors in the community as opposed to a
focus on those undergoing treatment or otherwise engaged in the cancer care system. The
rationale was that while motivation to quit and quit activity might be high during the
acute period of cancer diagnosis and active treatment (Burris et al., 2015; McBride,
Emmons, & Lipkus, 2003; Simmons et al., 2013), risk for relapse rises with time just as
social support tends to erode with time (Rivera & Burris, 2020). Thus, the primary
recruitment source was the population-based, statewide Kentucky Cancer Registry
(KCR). KCR is part of the National Cancer Institute Surveillance Epidemiology End
Results (SEER) Program and National Program of Cancer Registries. KCR has an
established, multistep process for recruitment into clinical trials and other research. For
individuals who fit the basic demographic and clinical eligibility parameters (e.g.,
residence in a rural county, larynx cancer) and for whom a history of tobacco use was
noted in the record, KCR informed the physician of record about the patient’s potential
for study participation and allowed that individual to withdraw the case from
consideration. If an individual passed this first step, the next step involved KCR
contacting the case by mail to inform them about the potential for study participation and
requesting that they consent (via the return of a pre-addressed, pre-stamped postcard) to
having their name and contact information released to investigators. If an individual
didn’t respond to the mailed invitation, KCR called them to obtain verbal consent. The
names and contact information for individuals who provided written or verbal consent
were then released to investigators. Other, supplementary sources of recruitment were
consistent with clinical trial accrual at the study institution and included researchers
8

contacting participants from previous studies (i.e., those who expressed interest in future
study participation) and physicians referring patients from Markey Cancer Center’s Head,
Neck, and Respiratory Clinic or Gynecologic Oncology Clinic.
2.4 ENROLLMENT
Upon receipt of the name and contact information of an interested person,
researchers called said individual to describe the study goals and procedures, screen for
eligibility, and reaffirm assess interest in study participation. Up to five calls on varying
days of the week and times of day were made in attempts to reach someone. For those
who are eligible and interested, researchers mailed a study packet with a consent form
and pre-paid, pre-addressed envelope for its return. Individuals who provided written
informed consent were enrolled and randomized into the study.
2.5 DATA COLLECTION
Upon enrollment, participants were scheduled for an assessment at Days 0, 30,
and 60. Assessments were done via a phone interview or paper-and-pencil questionnaire
that was sent and returned by mail at no charge to participants. Regardless of the mode of
data collection, data were entered and stored in a secure Research Electronic Database
Capture (REDCap) project.
2.6 MEASURES
The Day 0 assessment collected demographic information such as age, gender,
and socioeconomic status as well as participants’ tobacco use history (e.g., number of
cigarettes per day in the past week, quit behavior and tobacco treatment use in the past
year) via questions that are common in population-based surveys (CDC, 2017a; CDC,
2017b; USDC, 2012) and clinical research (Blake et al., 2016; Heatherton et al., 1989;
Land et al., 2016). Additionally, three items were used to assess participants’ perceptions
9

of NRT’s safety, effectiveness, and addictive liability (Mooney, Leventhal, & Hatsukami,
2006). Participants responded to the items on 5-point scale where 1 = Not at all and 5 =
Very, and items were averaged to create a total score where higher scores reflect more
favorable perceptions. The baseline assessment also included a Social Support Screener
that was developed for use in this study and designed to assess participants’ unmet needs
(see Appendix A). Similar to the National Comprehensive Cancer Network’s Problem
Checklist (Riba et al., 2019) and the Cancer Survivor Unmet Needs Questionnaire
(Hodgkinson et al., 2007), the 10-item Social Support Screener measures the amount of
help participants wanted with specific aspects of their physical, psychological, and social
functioning (e.g., cancer-specific health problems, other physical health problems,
relationships, basic needs) on a 11-point scale from 0 = No help wanted to 10 = Lots of
help wanted. These data are used to guide one component of the intervention (see Social
Support Resource Directory and Referral below) and tailor it to meet each participant’s
individual needs.
The Day 0, 30, and 60 assessments assessed key motivational and behavioral
outcomes in clinical trials for smoking cessation induction. Motivational outcomes were
measured with separate contemplation ladders for intention and confidence to abstain
from smoking over the next 30 days (Biener & Abrams, 1991), with scores ranging from
0 = Very definitely no to 10 = Very definitely yes and 0 = Not at all confident and 10 =
Extremely confident, respectively. Behavioral outcomes were assessed via timeline
follow-back procedures and include several indicators of smoking behavior and NRT use
(Aveyard et al., 2009; Velicer at al., 1992). Some of the outcomes were specific to
behavior in the seven days prior to the assessment (specifically, number of cigarettes per
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day), but most of outcomes focused on behavior in the past 30 days (e.g., any 24-hour
quit attempt, any NRT use, and number of days where the NRT patch and/or lozenge was
used). At follow-up, adverse events commonly found for the nicotine patch (e.g., skin
irritation, sleep problems) and nicotine lozenge (e.g., sore throat, nausea) were assessed
in terms of the presence or absence of the problem.
The Day 0, 30, and 60 assessments also measured participants’ knowledge and
use of the 25 resources described in the Social Support Resource Directly. Participants
reported their awareness of each resource (yes/no), and if they reported awareness, they
also reported if they used the resource in the past 30 days (yes/no).
The Day 60 assessment included the 4-item Treatment Acceptability and
Preferences measure (Sidani et al., 2009), on which participants rated the intervention in
terms of how reasonable it seemed, how suitable it was to their lifestyle, how effective it
was, and how willing they would be to use it again. Participants responded to each item
on a scale from 0 = not at all to 4 = very much, with total scores calculated as an average
of the items ( = .91); higher total scores indicate higher acceptability. Additionally,
participants were given the chance to elaborate on what they did or did not like about the
study via an open-ended response.
Finally, data pertinent to participants’ cancer diagnosis (e.g., site and stage) and
treatment (e.g., radiation) were obtained from KCR.
2.7 INTERVENTIONS
Rationale for Intervention Components. As outlined in the Introduction,
barriers to smoking cessation exist at multiple levels and include pro-tobacco cultural
norms plus social determinants of health such as low socioeconomic status, availability
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and affordability of high-quality healthcare, and chronic stress that impedes individuals’
motivation and ability to quit. The intervention being piloted is meant to address some of
the more practical barriers to smoking cessation as all intervention components are: 1)
remotely delivered – eliminating transportation barriers and facilitating access and 2)
provided at no cost – removing financial barriers to brief advice, and for the intervention
group, evidence-based pharmacotherapy in the form of NRT samples. Moreover, this
intervention is mindful of unmet needs that might otherwise dampen motivation to quit
(e.g., emotional problems, food shortage, housing insecurity) and therefore includes
tailored information and guidance about social support resources that could help.
Social Support Resource Directory and Referral. All participants received a
social support resource directory by mail and tailored referrals over the phone. The
directory was developed with the assistance of Markey Cancer Center’s Patient-Oriented
and Population Sciences Shared Resource Facility to ensure the most relevant, legitimate,
and accessible resources were included. The goal was to identify an array of resources at
the local, state, and national level that could help participants address general and cancerspecific unmet needs in these domains of social support: structural (i.e., the extent of
one's social network), emotional (i.e., things people do or say that make one feel loved,
understood, or appreciated), and instrumental (i.e., things people do to meet ones
practical or informational needs) (Uchino, 2004). For example, the Kentucky County and
District Health Departments provide instrumental social support through delivery of
preventative and other healthcare services (e.g., human papillomavirus vaccination,
diabetes management, cancer screenings) while the CancerCare, a national organization,
delivers structural, emotional, and instrumental social support through its offering of
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individual counseling, support groups, case management, financial assistance, and
educational workshops. Collectively, the 25 resources selected vary in their approach,
with a mix of social support delivery through personal encounters, phone calls, text
messages, written materials, and internet. While some of the resources used fee-forservice models, most did not charge or had only nominal fees. The 32-page directory was
professionally copyedited, printed in color and formatted such that each page described a
separate resource. For each resource, the information provided included the business or
organization’s mission statement, list of available services and any associated cost,
information about eligibility for services, steps to take to access the resource, and contact
information (see Appendix B for a list of the 25 resources and excerpts from the
directory).
All participants were scheduled for a 10–15-minute consultation with a master’s
level clinical psychology doctoral student who was also trained as a certified tobacco
treatment specialist. During this call, participants were asked to elaborate briefly on the
two unmet needs from the Day 0 assessment with the highest rating for “help wanted”; in
the case of a 3-way tie, participants were asked to choose two to discuss. Next, the
interventionist provided information about 2-3 social support resources that could help
address each participant’s unmet needs, thereby discussing 4-6 total resources.
Participants were told basic information about the resources, including how to access
them, and encouraged to use the resources in the next month. When the directory was
mailed, the pages that correspond to the resources discussed on the phone were flagged
for easy reference, though participants were encouraged to review the directory in its
entirety and seek out whatever resources they want.
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Brief Advice and Nicotine Replacement Therapy (NRT) Sampling.
Immediately after the consultation related to social support, participants in the treatment
group received a 10–15-minute consultation about smoking cessation. Akin to the
tailoring for social support, this consultation was tailored to each participant’s level of
motivation as reported at the Day 0 assessment. In this way, to establish rapport and
reduce defensiveness, participants who reported low motivation (0-3 scores) first
received messages that validate the perception of social and personal barriers that make it
challenging to quit smoking and told that they are not alone in their past experiences or
current stance on smoking cessation. In contrast, participants who reported moderate and
high levels of motivation (4-6 and 7-10 scores, respectively) first received clear, positive
reinforcement for their current motivation, especially in light of the challenges many
cancer survivors report related to smoking cessation. Consistent with the Clinical Practice
Guidelines for Treating Tobacco Use and Dependence (Fiore et al., 2008), participants
were then briefed on the benefits of smoking cessation, provided an overview of
evidence-based treatments for smoking cessation, and informed about the benefits, risks,
and formulations of nicotine replacement therapy (NRT) specifically. Participants were
encouraged to try a “practice” quit attempt where combination NRT serves to reduce
cravings and minimize withdrawal. Successful smoking cessation often requires multiple
attempts and skill development, so framing quit attempts in this way may alleviate
pressure to quit “for good” and increase willingness to try simultaneously (Carpenter et
al., 2010; Carpenter et al., 2011; Cheung et al., 2020; Dahne et al., 2020). To facilitate the
practice quit attempt, within the same shipment containing the social support directory,
participants received a free, two-week supply of nicotine patches (14 count box) and
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lozenges (72 count box) in original packaging. All participants received the 14mg dose of
NicoDerm CQ™ patches while the dose of Nicorette™ lozenges (2mg or 4mg) depended
upon participants’ time to first cigarette per the packaging label. Participants were
encouraged to try practice quit attempts and both NRT products in the next month, with
further encouragement to purchase more NRT if they exhausted the free samples.
2.8 DATA ANALYSIS
SPSS Version 20 was used to conduct most of the analyses. First, descriptive
statistics (e.g., means, frequencies) were used to describe the sample in terms of its
demographic, clinical, tobacco-related, and other characteristics. Independent samples ttests and chi-square tests were used to examine if there were statistically significant
(specifically, p < .05) group differences in key study variables at Day 0. Second, Aim 1
analyses of feasibility and acceptability were largely descriptive, but group differences in
the latter were also explored with an Independent samples t-test. For feasibility, the focus
was the KCR-specific accrual rate and the retention rates at the Day 30 and 60
assessments. For acceptability, the focus was on Treatment Acceptability and Preferences
scores at the Day 60 assessment as well as adverse events that occurred throughout
follow-up. Third, Aim 2 analyses considered these outcomes: intention to quit,
confidence in ability to quit, prevalence and amount of NRT patch and lozenge use,
number of cigarettes per day, prevalence of 50% smoking reduction, and prevalence and
number of any 24-hour quit attempts. For continuous outcomes, SAS Version 9.4 was
used such that SAS PROC MIXED tested whether there were significant group
differences in change from Days 0 to 30 and Days 0 to 60. For categorical outcomes,
SAS Version 9.4 was again used with Fisher’s Exact tests used to determine if there was
a significant group difference at Day 30 and Day 60 (separately), assuming no differences
15

between groups at Day 0 due to randomization. Finally, post hoc analyses involved
repeated measures analyses of variance to examine if change in social support resource
knowledge and use differed by group. For these analyses, a total score for each
participant was created by summing scores across the 25 resource variables.
CHAPTER 3. RESULTS
3.1 STUDY FLOW
The results of the recruitment, enrollment, and follow-up process are shown in
Figure 2. Between January 2018 and February 2019, investigators attempted to contact
170 cancer survivors who were identified through the primary recruitment source of
KCR. Of these, 60.00% (n=102) were reached and screened for eligibility, and 32.40%
(n=33) of these were eligible. The main reasons for cancer survivors’ ineligibility were
their place of residence, their report of smoking fewer than 100 cigarettes smoked in their
lifetime, and their report of smoking fewer than 10 cigarettes per day, on average, in the
past month; options not mutually exclusive. Over half (66.67%, n=22) of the eligible
cancer survivors recruited through KCR were enrolled into the study. The enrollment of
22 of the 170 KCR cases represents an overall accrual rate of 12.94%. After KCR
recruitment was completed, study participation was opened to cancer survivors identified
through other avenues of recruitment, which yielded 27 additional participants, bringing
the sample size to n=49.
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FIGURE 2 STUDY FLOW

1
Note. LTF = lost to follow-up; NRT = nicotine replacement therapy; In Recruitment
section, reasons for ineligibility are not mutually exclusive. In Treatment and Follow-Up
section, the data in the middle boxes pertains to the Control Group and Treatment Group,
respectively.

17

3.2 SAMPLE CHARACTERISTICS AT BASELINE
The sample’s (n=49) demographic, clinical, and tobacco use characteristics are
detailed in Tables 1, 2, and 3, respectively and are discussed in turn below. Following
this, information about participants’ unmet needs and related resources are summarized,
with full details for unmet needs shown in Figure 3. At the Day 0 assessment, with one
exception (for electronic/vape products), there were no statistically significant group
differences on any of the variables discussed below.
Consistent with the eligibility criteria, rural (67.35%, n=33) and Appalachian
(85.71%, n=42) county residence at the time of cancer diagnosis were both common
among participants and not mutually exclusive. Females comprised 48.98% (n=24) of the
sample. The racial and ethnic background of participants was majority White, nonHispanic (91.84%, n=45). Participants in a relationship comprised 38.78% (n=19) of the
sample, with a similar proportion being divorced (32.65%, n=16). The sample consisted
of 38.78% (n=19) people who had obtained a high school degree and 6.12% (n=19) who
had obtained a college degree. Roughly half of the sample reported that they were
disabled and unable to work (53.06%, n=26). Most participants identified their annual
household income as $24,999 or less (70.83%, n=34). Finally, participants’ average age
was 55.42  9.57 years.
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TABLE 1 SAMPLE DEMOGRAPHIC CHARACTERISTICS AT BASELINE (N=49)
Variable
Rural residence
Yes
No
Appalachian residence
Yes
No
Sex
Male
Female
Race
White, non-Hispanic
Black, non-Hispanic
Relationship Status
Married or partnered
Divorced
Single
Other f
Highest Education Level
Less than high school degree
High school or GED equivalent
Some college or technical school
College graduate
Employment Status
Disabled
Unemployed
Employed
Retired
Health Insurance
Yes
No
Annual household income
Less than $10,000
$10,000 to $14,999
$15,000 to $24,999
$25,000 to $49,999
$50,000 or more
Missing
Age, years c

Sample
% (n) a

Control
% (n) a

Treatment
% (n) a

67.35 (33)
32.65 (16)

68.00 (17)
32.00(8)

66.67 (16)
33.33 (8)

85.71 (42)
14.29 (7)

80.00 (20)
20.00 (5)

91.67 (22)
8.33 (2)

51.02 (25)
48.98 (24)

60.00 (15)
40.00 (10)

41.67 (10)
58.33 (14)

91.84 (45)
8.16 (4)

92.00 (23)
8.00 (2)

91.67 (22)
8.33 (2)

38.78 (19)
32.65 (16)
16.33 (8)
12.24(6)

40.00 (10)
36.00 (9)
20.00 (5)
4.00 (1)

37.50 (9)
29.17 (7)
12.50 (3)
20.83 (5)

18.37 (9)
38.78 (19)
36.73 (18)
6.12 (3)

24.00 (6)
44.00 (11)
28.00 (7)
4.00 (1)

12.50 (3)
33.33 (8)
45.83 (11)
2.00 (2)

53.06 (26)
14.29 (7)
18.37 (9)
14.29 (7)

44.00 (11)
16.00 (4)
20.00 (5)
20.00 (5)

62.50 (15)
12.50 (3)
16.67 (4)
8.33 (2)

91.84 (45)
8.16 (4)

88.00 (22)
12.00 (3)

95.83 (23)
4.17 (1)

Statistical Test b
0.01 (1), p = .92

1.36 (1), p = .24

1.65 (1), p = .12

0.00 (1), p = .97

3.45 (3), p = .33

2.67 (3), p = .44

2.14 (3), p = .55

1.00 (1), p = .32

1.90 (4), p = .76
32.00 (8)
30.43 (7)
24.00 (6)
30.43 (7)
8.00 (2)
17.39 (4)
20.00 (5)
13.04 (3)
16.00 (4)
8.70 (2)
0.00 (0)
4.20 (1)
56.00 
54.78  9.27 0.44 (1), p = .64 d
10.01
Notes. a Data are frequencies (percentages) unless otherwise noted. Percentages across groups may not sum to 100.00 due to rounding;
b
Test is a chi-square unless other noted; c Test is an Independent samples t-test; d Data are means  standard deviations; e Other
corresponds to homemaker, student, or retiree; f Other corresponds to widowed, separated, or dating.
31.25 (15)
27.08 (13)
12.50 (6)
16.67 (8)
12.50 (6)
2.00 (1)
55.42  9.57
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There were twice as many head/neck cancer survivors (65.31% (n=32) than
cervical cancer survivors (34.69% (n=17) in this study. Cancer stage was evenly
distributed, as 20.41% (n=10) of participants had Stage I and 22.45% (n=11) of
participants had Stage IV. Regarding cancer treatment, participants most often received a
combination of radiation and chemotherapy (30.61%, n=15), but many treatments were
represented. Lastly, the average time since diagnosis was 2.05 ± 1.31 years.
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TABLE 2 SAMPLE CLINICAL CHARACTERISTICS AT BASELINE (N=49)
Variable

Sample
% (n) a

Control
% (n) a

Treatment
% (n) a

Cancer site
1.50 (1), p = .22
Cervical
33.33 (16)
25.00 (6)
41.67 (10)
Head and neck
66.67 (32)
75.00 (18)
58.33 (14)
Missing
2.04 (1)
Cancer stage
1.60 (3), p = .66
I
20.41 (10)
19.05 (4)
33.33 (6)
II
24.49 (12)
38.10 (8)
22.22 (4)
III
12.24 (6)
14.29 (3)
16.67 (3)
IV or metastatic
22.45 (11)
28.57 (6)
27.78 (5)
Missing
20.41 (10)
8.16 (4)
12.24 (6)
Cancer stage
1.65 (2), p = .43
Localized
10.50 (12)
38.10 (8)
23.53 (4)
Regional
47.37 (18)
37.10 (8)
58.82 (10)
Distant or metastatic
21.05 (8)
23.81 (5)
17.65 (3)
Missing
22.45 (11)
8.16 (4)
14.29 (7)
Treatment type
7.64 (6), p = .26
Surgery only
14.29 (7)
4.55 (1)
27.27 (6)
Radiation only
4.08 (2)
4.55 (1)
4.55 (1)
Radiation and chemotherapy
30.61 (15)
45.45 (10)
22.73 (5)
Radiation and surgery
16.33 (8)
18.18 (4)
18.18 (4)
Surgery, radiation, chemotherapy 20.41 (10)
18.18 (4)
27.27 (6)
Missing
10.20 (5)
6.12 (3)
4.08 (2)
Time since diagnosis, years b
1.49 (42), p = .14
2.05  1.31
2.34  1.36
1.76  1.21
Notes. a Data are frequencies (percentages) unless otherwise noted. Percentages across groups may not sum to 100.00 due to rounding;
b
Data are means  standard deviations
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Participants reported smoking an average of 16.3 ± 12.4 cigarettes per day, with
76.10% (n=35) smoking their first cigarette within an hour of waking. Of current
smokers, 16.32% (n=8) reported using electronic cigarette or vape products in the past
month; no other forms of tobacco use were reported for past month behavior. Regarding
tobacco cessation, most participants reported a lifetime history of at least one 24 hour
quit attempt (79.59%, n=39). Consultation with or brief advance from a physician or
other healthcare provider was the most common form of tobacco cessation treatment
(53.01%, n=26). Participants’ lifetime use of individual or group counseling was
comparatively much lower (14.29%, n=7). Lifetime use of smoking cessation
medications other than NRT was present in over half of participants (66.67%, n=26).
Participants viewed NRT as moderately safe (3.08 ± 1.33), moderately addictive (2.63 ±
1.30), and moderately effective (2.92 ± 1.30); total score = 2.88 ± 0.89. About half of
participants reported use of NRT patches in their lifetime (46.9%, n=23). Other forms of
NRT were less popular with 20.41% (n=10) reporting lozenge use, 24.45% (n=12)
reporting gum use, and 8.16% (n=4) reporting inhaler or nasal spray use; all lifetime
rates. Finally, at baseline, participants’ intention and confidence to quit smoking was low
with average scores of 4.63 ± 3.62 and 2.84 ± 3.26, respectively.
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TABLE 3 TOBACCO USE AND RELATED HISTORY AT BASELINE (N=49) A
Sample
Variable

% (n)

a

Control
% (n)

a

Treatment
% (n)

Statistical Test

a

Tobacco Use
Cigarette smoking
Currently living with smoker

61.22 (30)

62.50 (15)

62.50 (15)

Time to First Cigarette

0.00 (1), p = 1.00
4.12 (3), p = .25

Up to 5 Minutes

8.70 (4)

4.55 (1)

12.50 (3)

6 to 30 Minutes

8.70 (4)

9.09 (2)

8.33 (2)

31 to 60 Minutes

58.70 (27)

50.00 (11)

66.67 (16)

60 or more Minutes

23.91 (11)

36.36 (8)

12.50 (3)

Cigarettes per day, past week

13.18 ± 8.72

1.71 (46), p = .09

Electronic or vape product, lifetime

16.32 
12.43
46.94 (23)

19.20 ±
14.65
32.00 (8)

62.50 (15)

4.57 (1), p = .03

Other tobacco use, lifetime

16.33 (8)

8.00 (2)

12.24 (6)

2.59 (1), p = .11

Intention to Quit

4.63  3.62

4.08  3.51

5.21  3.73

-1.09 (47), p = .14

Confidence to Quit

2.84  3.26

2.36  3.20

3.33  3.32

-1.05 (47), p = .15

Lifetime

79.59 (39)

76.00 (19)

83.33 (20)

0.41 (1), p = .52

Past year

59.18 (29)

26.53 (13)

32.65 (16)

0.69 (1), p = .41

Past month

16.33 (8)

13.79 (4)

13.79 (4)

0.12 (1), p = .73

Nicotine patch

46.94 (23)

20.41 (10)

26.53 (13)

0.61 (1), p = .43

Nicotine lozenge

20.41 (10)

10.20 (5)

10.20 (5)

0.01 (1), p = .91

Nicotine gum

24.45 (12)

10.20 (5)

14.29 (7)

0.35 (1), p = .56

Other NRT

8.16 (4)

4.08 (2)

4.08 (2)

0.00 (1), p = .96

Other Medications b

16.33 (26)

14.29 (13)

2.04 (13)

1.08 (1), p = .59

Counseling c

14.29 (7)

26.32 (5)

10.00 (2)

2.28 (1), p = .32

Physician consult d

53.01 (26)

61.11 (11)

75.00 (15)

4.24 (1), p = .12

2.88  

2.72  

  

-1.19 (46), p = .12

Smoking Cessation Behavior

24-hour Quit attempt

Tobacco Treatment Use, Lifetime

NRT Attitudes (α = .43)
Total score (0-5 scale) e
a

Notes. Data are frequencies (percentages) unless otherwise noted. Percentages across groups may not sum to 100.00 due to rounding;
b
Includes Wellbutrin and Varenicline.; c Denotes counseling services, including those from a quit line; d Includes oncologist and any
other physicians; e Total score reflects items that measure perceived safety, addictive liability, and effectiveness of NRT
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As shown in Figure 3, participants reported unmet needs across all domains
measured in this study. There were no significant differences in “help wanted” between
groups (ps=.20 - .49). The three domains in which participants wanted the most help
were tobacco cessation, cancer, and psychological health. Also, there was wide
variability in terms of participants’ basic knowledge and past month use of the 25 social
support resources outlined in the directory (data not shown; no differences between
groups). In general, participants’ knowledge far exceeded their use of the resources (e.g.,
79.59% of participants knew about the American Cancer Society while only 4.08% of
them reported any use of it). The most known resources were American Cancer Society
(79.59%, n=39), CVS Pharmacy (57.14%, n=28), CancerCare (55.10%, n=27), local
health departments (51.02%, n=25), and Cancer Information Service (44.89%, n=22),
most of which pertain to cancer survivorship. The most used social support resources
were CancerCare (8.16%, n=4), Community Action Kentucky (8.16%, n=4), CVS
Pharmacy (6.12%, n=3), and American Cancer Society (4.08%, n=2) while the other
resources were reported at negligible rates.

24

FIGURE 3 AMOUNT OF HELP WANTED AT BASELINE

Note. Descriptive data for help wanted at baseline, reported as means. Independent
samples t-test yielded no significant differences between groups (ps=.20–.49)
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3.3 TREATMENT ACCEPTABILITY
The treatment group’s score on the acceptability measure was 2.84  1.09 while
the control group reported a significantly lower score of 1.99  1.38 (t(31)=-1.97, p=.03).
In response to the open-ended question about their impressions of the intervention, most
comments from the treatment group were positive in nature. For example, one participant
stated, “Having the patches and the lozenges has really helped me. Before when I just
used the patches, I was still having the cravings to smoke, but having the lozenges this
time has really helped when I get a craving!” Another participant remarked, “Even just
putting the study out there is good. Thank you for just helping us to think about what we
need to quit.” Some participants did make critical remarks, all of which were NRTspecific (e.g., “The patches didn't help… The lozenges made me sick to my stomach”).
No serious adverse events were identified. For the control and treatment groups,
respectively, the five most common adverse events were insomnia (n=7 and 8), dry
mouth (n=6 and 7), dizziness (n=5 and 8), weakness (n=4 and 8) and breathing difficulty
(n=6 and 5). Of note, the report of some of these adverse events might be at least partly
attributable to their cancer experience.
3.4 FOLLOW-UP DATA
Social Support Resources at Follow-Up
As depicted in Figure 4, social support resource knowledge changed significantly
over time (p<.01), with knowledge showing an initial increase with a decline thereafter.
There was not a significant group by time effect, however (p=.22). As shown in Figure 5,
social support resource use also changed significantly over time (p<.01), with the same
curvilinear trend and no significant group by time effect (p=.13). Thus, while there were

26

some favorable changes observed in social support resource knowledge and use, the
pattern of change did not differ between the treatment and control groups.
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FIGURE 4 SOCIAL SUPPORT RESOURCE KNOWLEDGE ACROSS TIME AND BY GROUP

Note. Results of the repeated measures ANOVA for resource knowledge group by time:
F(2) = 1.53, p=.22.
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FIGURE 5 SOCIAL SUPPORT RESOURCE USE ACROSS TIME AND BY GROUP

Note. Results of the repeated measures ANOVA for resource use group by time. F(2) =
1.66, p=.13.

29

NRT at Follow-Up
As shown in Table 4, NRT use was low among all participants during the followup period. For the number of days of NRT patch use in the past month, change from
baseline to follow-up in the treatment and control groups did not differ at Day 30 (p=.97)
or Day 60 (p=.93). Similarly, for the number of days of NRT lozenge use in the past
month, change from baseline to follow-up in the treatment and control groups did not
differ at Day 30 (p=.58) or Day 60 (p=.08). Finally, for the overall prevalence of any
NRT patch use in the past month, there were significant group differences during followup, with the treatment group reporting a higher prevalence of use than the control group
at both Day 30 (63.16% vs. 14.28%; p<.01) and Day 60 (64.71% vs. 16.67%; p<.01).
Similarly, for the overall prevalence of any NRT lozenge use in the past month, there
were significant group differences during follow-up, with the treatment group reporting a
higher prevalence of use than the control group at Day 30 (50.00% vs. 4.76%; p<.01) and
Day 60 (58.82% vs. 0.00%; p<.01). Thus, while NRT use was low overall, the treatment
group tried this product to a greater extent than the control group.
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TABLE 4 SELECT SMOKING-RELATED MOTIVATION AND BEHAVIORAL VARIABLES OVER
TIME AND BY GROUP
Intention to Quit
 from baseline b

Day 0
Control
Treatment
4.08  3.51 5.21  3.73
-

Confidence to Quit a
 from baseline b

2.26  3.20
-

3.33  3.32
-

Cigarettes per day, past
week a
 from baseline b

19.20 
14.65
-

13.18 
8.72
-

Variable

Day 30
Control
Treatment
4.14 ± 3.12 6.47 ± 3.59
-0.05 ±
1.29 ± 0.81
0.78
3.24 ± 3.22 3.37 ± 3.41
0.76 ± 0.74 -0.23 ±
0.78
18.91 ±
11.13 ±
13.69
7.21
1.25  1.60 -2.86 
1.67
1.43 ± 6.55 3.17 ± 7.21

NRT lozenge use days,
0.00  0.00 0.00  0.00
past month
1.43 ± 1.22 2.43 ± 1.36
 from baseline b
NRT patch use days,
1.43 ± 4.51 4.94 ± 5.82
0.00  0.00 0.00  0.00
past month
1.14 ± 1.74 1.05 ± 1.91
 from baseline b
Notes. a Data are mean ± standard deviation; b Data are mean ± standard error.
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Day 60
Control
Treatment
4.56 ± 3.45 5.88 ± 3.89
0.33 ± 0.81 1.07 ± 0.84
2.89 ± 3.46
0.50 ± 0.79
16.83 ±
11.79
-1.67 
1.70
0.00 ± 0.00

3.41 ± 2.74
-0.16 ±
0.81
9.14 ± 5.65
-3.65 
1.25
5.29 ± 8.45

0.01 ± 1.33
2.33 ± 7.18

3.39 ± 1.41
6.82 ± 9.49

1.90 ± 1.85

2.12 ± 1.96

Motivation and Smoking Behavior at Follow-Up
As shown in Table 4, during the follow-up period, the treatment group appeared
to report higher levels of intention and confidence to quit smoking than the control group.
However, the analyses of change over time revealed no statistically significant
differences between groups. First, for intention, change from baseline to follow-up in the
treatment and control groups did not differ at Day 30 (p=.24) or Day 60 (p=.53). Second,
the same result was observed for confidence (ps=.36 and .56 for Days 30 and 60,
respectively). Third, for the average number of cigarettes per day in the past week (see
Table 4), change from baseline to follow-up in the treatment and control groups did not
differ significantly at Day 30 (p=.08) or Day 60 (p=.42). While results showed that the
treatment group reported a larger decrease in cigarettes per day than the control group,
the treatment group started with a higher number of cigarettes per day at baseline
(although not statistically different), which might explain the null result for change over
time. Fourth, for the occurrence of 50% smoking reduction (specifically, a 50% or greater
reduction from baseline) based on data from the last week, results did not differ
significantly between the treatment and control groups at Day 30 (21.05% vs. 14.30%;
p=.68) or Day 60 (41.12% vs. 16.67%; p=.15), though the raw data favors the treatment
group (again likely due to the baseline group differences). Finally, while the occurrence
of one or more 24-hour quit attempts in the past month did not differ between the
treatment and control at Day 30 (36.84% vs. 33.33%), it did differ at Day 60 (58.89% vs.
16.67%), again with a pattern that favors the treatment group.
CHAPTER 4. DISCUSSION
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In response to well documented and clinically meaningful inequities in smoking
cessation rates across geographic areas and socioeconomic strata (Doescher et al., 2006;
Hu et al., 2016; Jamal et al., 2015; Lui et al., 2016; Mitchell et al., 2016; Nguyen et al.,
2016), this study aimed to test a novel intervention in a disadvantaged population.
Capitalizing on the rigor of a RCT, this pilot study evaluated the feasibility, acceptability,
and impact of a new and nimble approach to smoking cessation induction (namely, NRT
sampling + social support resource referral). The results of this study demonstrate
strengths and weaknesses of the approach, with a summary assessment suggestive of a
recruitment approach with an undesirable cost-benefit ratio and an intervention with
remarkable acceptability, yet mixed effects on the ability to engage cancer survivors in
the process of smoking cessation.
One of the main study objectives was to examine the feasibility of using a
statewide, population-based cancer registry to recruit cancer survivors who smoke into a
clinical trial. As a state-based cancer registry, KCR provided an opportunity to identify
cancer survivors in the community, people who might otherwise not be accessible
because they are not actively engaged with the cancer care system. Another inherent
benefit of working with a large cancer registry is the ability to potentially identify a large
number of current smokers. However, in addition to out-of-date contact information and
inability to contact due to death, there is the complication of changes in behavior over
time. To explain, the information on smoking behavior in a cancer registry is extracted
from information available in the electronic health record at the time of cancer diagnosis,
and the smoking behavior of cancer survivors (Tseng et al., 2012; Talluri et al., 2020),
just like people in the general population (Bondy et al., 2013; Cornelius et al., 2020), may
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change over time. In this study, the primary reason for ineligibility was that the person
was no longer smoking, and this occurred even with recruitment efforts that centered on
people who were smoking at cancer diagnosis. Thus, even though a cancer registry is a
novel approach to recruitment of cancer survivors into clinical trials for smoking
cessation (induction) (Rettig et al., 2018; Silvestri et al., 2021), due to the low overall
accrual rate and associated financial cost, it may not be cost-effective. That aside, once
recruited into the study, cancer survivors tended to stay in the study, as indicated by an
overall retention rate of 84% at Day 30 and 73% at Day 60. This is comparable to other
studies who aimed to recruit unmotivated smokers in a general population (Carpenter et
al., 2020; Harris et al., 2016). Compared to studies that focus recruitment on cancer
survivors, the current trial was able to retain participants at a higher rate than some
(Lelaurin et al., 2020; Park et al., 2020). Despite the comparable or in some cases more
favorable retention rates, it cannot be ignored that the participants who dropped out of the
study may have differed in important ways from those who were retained, particularly in
terms of their smoking behavior. All things considered, in future attempts to engage
community-based cancer survivors who smoke, it may be more feasible to establish
partnerships with public health departments, local wellness centers (e.g., YMCAs), or
community/lay health workers, all of which would still constitute innovative recruitment
approaches for smoking-related studies with cancer survivors.
In addition to examining the feasibility of recruiting and retaining a communitybased sample of cancer survivors who smoke into a clinical trial, the other main study
objective was to establish the acceptability of the treatment approach. Encouragingly,
participants in the treatment group endorsed scores on a standardized measure that reflect
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moderate acceptability (Sidani et al., 2009), scores that were significantly higher than
those observed in the control group. Positive written feedback from participants in the
treatment group centered around the free resources offered (both the social support
resource guide and the smoking cessation medication) and the overall mission of trying to
aid their smoking cessation. Some of the particularly appealing aspects of the treatment
were likely the absence of any associated cost, the fact that there was no need for
transportation, individual and personalized based treatment, and the provision of
combination NRT, which some participants reported trying for the first time. Negative
feedback mostly concerned adverse events related to NRT such as sore throat or trouble
sleeping, which are common among NRT users (Mills et al., 2010). Importantly, no
serious adverse events were reported in this study. Other than what was mentioned by
participants, it is possible people were dissatisfied with the minimal level of interaction
with the interventionist (i.e., one session with no booster) and the provision of a small
amount of medication (i.e., a two-week supply). Overall, cancer survivors’ judgements
about this novel treatment were largely favorable, and their perceived weaknesses are not
insurmountable.
For some of the variables one might expect to explain desired changes in smoking
behavior, there were promising results. Specifically, within the treatment group,
participants’ familiarity with and use of social support resources and their uptake of NRT
all showed positive gains, at least in the short-term. For the social support outcomes,
changes observed from Day 0 to 30 mostly deflated by Day 60 and while NRT use
increased, it remained at clinically ineffective levels (Hsia et al., 2017; Wadgave &
Nagesh, 2016). The initial increase in knowledge about social support resources was
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expected and can be attributed to the brief advice session that was designed with this goal
in mind. Unexpectedly, self-reported knowledge of those same resources dropped over
time. This is likely a function of participants initially looking into the resources, and then
not following-up or engaging with them and subsequently forgetting what they learned.
To explain the low overall rates of social support resource use, it is important to
recognize that the current trial took an ask-advise-refer approach. In this approach,
providers (or others) ask people about their tobacco use (or unmet needs), advise them on
the benefits of quitting (or using available resources), and then refer them to resources
that can help address the problem of tobacco use (or unmet needs) (Schroeder, 2005).
Though this approach was chosen in to maximize feasibility and scalability, evidence
demonstrates that an ask-advice-connect approach is more likely to result in
treatment/resource engagement (Piñeiro et al., 2020; Vidrine et al., 2013; Wolf et al.,
2020). Thus, people are more likely to use treatments and resources when they are
directly connected to the source as opposed to given a referral and instructed to contact
the source on their own, which was the approach here. Of course, the ask-advise-refer
approach does not explain the underwhelming amount of NRT use in the treatment group,
as that was provided without cost and directly delivered. One explanation for the lower
than desired NRT use is that attitudes towards NRT may not have improved postintervention. Compared to other studies, the current intervention spent far less time
interacting with participants regarding the safety, use, and effectiveness of medications as
this intervention involved brief advice only. This may explain possibly unchanging
attitudes towards NRT (Pacek, McClernon, & Bosworth, 2018; Schlam et al., 2018),
which in turn might explain the limited NRT use (Malik, Kumari, & Manalai, 2020; Silla,
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Beard, & Shahab, 2014; Yong et al., 2022). Additionally, as mentioned earlier, some
participants did experience adverse events commonly associated with NRT use, and that
negative personal experience might have led to generally low uptake and infrequent,
time-limited use. In summary, it may be advantageous for future interventions to adopt an
ask-advice-connect approach along with modifications to improve attitudes towards
NRT.
This clinical trial’s emphasis on smoking cessation induction places particular
importance on variables that precede and predict abstinence such as high levels of
intention and confidence to quit (Clyde et al., 2019; Little et al., 2018; Paul et al., 2019).
Promisingly, all participants reported an increase in their intention to quit from Day 0 to
Day 30. However, at Day 60, intention to quit basically reverted to rates resembling Day
0. Furthermore, change in intention for participants in the treatment versus the control
group did not differ significantly. Given that participants in the treatment group were
provided free NRT samples shortly after receipt of brief advice to quit, an increase of
intention was expected as participants were thought to be primed and ready for a quit
attempt. Indeed, this feature of the intervention design and observed outcome converges
with prior studies (Carpenter et al., 2010; Carpenter et al., 2020; Nightingale et al., 2019).
However, the singular intervention session involving brief advice may have been lacking
in its ability to spur long-term, substantial changes in intention to quit. It is also possible
that participants tried to quit shortly after speaking with the interventionist and receiving
the resource guide and NRT, did not experience marked success, and then determined
that they weren’t “ready” to quit “for good.” Notably, some previous clinical trials that
have also indicated intention as an intervention target involved multiple sessions of
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motivational interviewing, an evidence-based intervention designed to empower
individuals to pursue meaningful change (e.g., quitting smoking, increasing exercise)
(Cately et al., 2016; Lindson et al., 2019; Spencer & Wheeler, 2016). Thus, to expect
similar changes with a comparably low level of intervention may have been too
optimistic, especially in a sample characterized by multiple barriers to smoking cessation
(Babb et al., 2017; Cardarelli et al., 2021; Schoenberg, et al., 2015). This is perhaps a fair
interpretation given that confidence to quit remained low throughout the study. Some
studies that have successfully reported increases in confidence to quit took the approach
of delivering health education (Cately et al., 2016; Golechha, 2016; Guillaumier et al.,
2021), which was not the focus here. Consequently, in the context of a low-education
population, it makes sense that this intervention’s omission of extensive health education
yielded little to no improvement in confidence. Taken together, future interventions may
benefit from pairing free NRT sampling with a more elaborate approach to boosting
motivation such as health education and/or motivational interviewing.
In addition to motivational outcomes, the current trial measured multiple
behavioral outcomes that represent key events in the early stages of smoking cessation,
specifically number of cigarettes per day on smoking days, 50% smoking reduction, and
24-hour quit attempts (Cahill et al., 2013; Carpenter et al., 2010; Carpenter et al., 2020;
Jardin et al., 2014; Li et al., 2018). For both cigarettes per day and 50% smoking
reduction, the treatment group tended to decrease smoking behaviors at higher rates
though they did not rise to statistical significance. This null result is likely due to
differences in smoking behavior at baseline in combination with low statistical power due
to the small sample size. Regardless, because smoking reduction predicts eventual
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abstinence (Klemperer, Hughes, & Naud, 2019; Klemperer et al., 2020), the treatment
group outpacing the control group two-fold can be considered clinically significant. As
another indicator of positive behavioral change, the treatment group did show
significantly higher rates of 24-hour quit attempts at the Day 60 follow-up. Stated plainly,
the delivery of a free sample of NRT mailed directly to them plus brief advice to quit and
tailored recommendations about social support resources that could address their unmet
needs did seem to ignite some measure of readiness to quit, as evidenced by attempting a
24-hour quit attempt at least once. As a very minimal and low-cost intervention, this is a
promising result and future studies should investigate this further, making sure to
evaluate to what extent varying levels of motivation and tailored quit advice impact any
subsequent changes in behavior.
Finally, the study results must thoroughly be considered in light of limitations in
the study methodology. First, social support advice and aid in navigating relevant
resources were condensed to a single session. The potency of this aspect of the
intervention was likely insufficient as resource knowledge and use declined precipitously
over time. Though there is practical benefit to brief interventions and the possibility of
scalability is high (Marshall et al., 2016; Wray et al., 2018), the deconstruction of social
support barriers may be too large a task for a single session, especially when working
with disadvantaged groups (Marshall et al., 2016; van Wijk, Landais, & Harting, 2019).
In addition, since all participants received the social support resource guide and
consultation session, the changes observed in social support resource knowledge and use
cannot be definitively attributed to the intervention, as there is no true control group for
this aspect of the intervention. Second, the intervention components were all completely
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free. This includes the physical social support resource guide, brief advice and referral
information provided over the phone, and direct-to-consumer NRT samples via mail. It
may be unrealistic to assume that this kind of intervention would be available in lessfunded clinics in low-resource areas. However, all state quitlines provide free advice and
counseling sessions, and some provide 6-12 weeks of NRT for free by mail (Kentucky
Cancer Program, 2022; Cabinet for Health and Family Services, 2022). Plus, as identified
in the social support resource guide, there are non-profit organizations that deliver free
and low-cost services to cancer survivors with financial need. Thus, it might be possible
for some government-funded clinics and non-profit organizations to provide an
intervention like the one tested here, even if private clinics would not be in the position to
do so. Without a clear demonstration of efficacy and cost-effectiveness, though, the
matter is mute. Third, there was no attempt to biochemically verify the smoking status of
participants who self-reported abstinence, and there is no objective means to confirm the
occurrence of fleeting quit attempts (Benowitz et al., 2020). Since cancer survivors and
other patient groups are known to misrepresent their smoking status (Mejia et al., 2017;
Scheuermann et al., 2017), even in low pressure situations like this one, it is possible the
observed abstinence and quit attempt rates are inflated. However, the likelihood of that is
low because there was no inducement for smoking cessation and participants were not
engaged with any healthcare system as part of this study. Finally, this sample of cancer
survivors consisted of mostly older, white smokers. This was a consequence of the focus
on rural, Appalachian communities in Kentucky, but to truly address barriers and
inequities to smoking cessation, future studies need to expand their efforts to include
sexual minorities, racial minorities, and other groups who smoke at disproportionally
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higher rates and/or experience more difficulties with smoking cessation (Agaku et al.,
2014; Kochanek et al., 2016). Any attempts to engage a more diverse sample should also
be mindful of including smokers from the lower end of socioeconomic status, as was
done here. In future studies, there needs to be careful consideration of the balance of
intervention potency and disseminability, possibly with the adoption of biochemical
verification of smoking status, and evaluation in diverse samples from multiple
geographic regions.
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APPENDIX
Appendix A. Social Support Screener
Instructions: Using the 0-10 scale below, please indicate to what extent you want or need
help with…

0

1

2

3

4

5

No help
wanted

6

7

8

9

10
Lots of
help
wanted

1. _____ Relationships (e.g., strengthening your connection to friends or family)
2. _____ Cancer (e.g., understanding your diagnosis, coping with treatment)
3. _____ Physical health problems other than cancer (e.g., high blood pressure,
diabetes)
4. _____ Psychological or emotional health problems (e.g., depression, anxiety)
5. _____ Tobacco cessation (e.g., quitting use of cigarettes, e-cigs, etc.)
6. _____ Behavior change other than tobacco cessation (e.g., dieting, exercising)
7. _____ Healthcare access (e.g., finding, getting, and affording it)
8. _____ Finances (e.g., managing bills, saving money)
9. _____ Employment (e.g., finding a new job, getting training)
10. _____ Household management (e.g., cooking, cleaning, caring for children)
11. _____ Basic needs (e.g., availability of food, clothing, and shelter)
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Appendix B. List of the Social Support Resources and Page Excerpts from the Social
Support
Resource Guide
American Cancer Society
Become an EX
Cancer Information Service
CancerCare
Cervivor
Community Action Kentucky
CVS Pharmacy
Friend for Life
Kentucky Association of Food Banks
Kentucky Cancer Link
Kentucky Community Mental Health Centers
Kentucky HANDS Program
Kentucky Homeplace
Kentucky Rx Card
Local Health Departments
National Cervical Cancer Coalition
Needy Meds
Pathfinder
Quite Guide App
Quit Now Kentucky
SmokefreeTXT
Springboard Beyond Cancer
United Way 2-1-1
UK Extension Program
Yellow Umbrella Organization
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